SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-025976
Filing Date
2024-07-02
Accepted
2024-07-02 15:35:53
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1484801
2 ex31-1.htm EX-31.1 17161
3 ex31-2.htm EX-31.2 17358
4 ex32-1.htm EX-32.1 9379
  Complete submission text file 0001493152-24-025976.txt   7897540

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE qlgn-20240331.xsd EX-101.SCH 67614
6 XBRL CALCULATION FILE qlgn-20240331_cal.xml EX-101.CAL 59491
7 XBRL DEFINITION FILE qlgn-20240331_def.xml EX-101.DEF 284926
8 XBRL LABEL FILE qlgn-20240331_lab.xml EX-101.LAB 474454
9 XBRL PRESENTATION FILE qlgn-20240331_pre.xml EX-101.PRE 385472
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1437152
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 241094773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)